Pharmagreen Biotech (Pharmagreen Biotech) Total Assets : $0.14 Mil (As of Jun. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Pharmagreen Biotech Total Assets?

Pharmagreen Biotech's Total Assets for the quarter that ended in Jun. 2023 was $0.14 Mil.

During the past 12 months, Pharmagreen Biotech's average Total Assets Growth Rate was -19.20% per year. During the past 3 years, the average Total Assets Growth Rate was -29.20% per year.

During the past 7 years, Pharmagreen Biotech's highest 3-Year average Total Assets Growth Rate was 5.40%. The lowest was -29.20%. And the median was -11.90%.

Total Assets is connected with ROA %. Pharmagreen Biotech's annualized ROA % for the quarter that ended in Jun. 2023 was -430.36%. Total Assets is also linked to Revenue through Asset Turnover. Pharmagreen Biotech's Asset Turnover for the quarter that ended in Jun. 2023 was 0.01.

Pharmagreen Biotech Total Assets Historical Data

The historical data trend for Pharmagreen Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmagreen Biotech Total Assets Chart

Pharmagreen Biotech Annual Data

Trend

Apr08

Apr09

Sep18

Sep19

Sep20

Sep21

Sep22

Total Assets

Get a 7-Day Free Trial

0.45

0.63

0.27

0.37

0.21

Pharmagreen Biotech Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Total Assets	Get a 7-Day Free Trial															0.19	0.21	0.21	0.16	0.14

Pharmagreen Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Pharmagreen Biotech's Total Assets for the fiscal year that ended in Sep. 2022 is calculated as

Total Assets	=	Total Equity (A: Sep. 2022 )	+	Total Liabilities (A: Sep. 2022 )
	=	-1.823	+	2.032
	=	0.21

Pharmagreen Biotech's Total Assets for the quarter that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2023 )	+	Total Liabilities (Q: Jun. 2023 )
	=	-2.151	+	2.291
	=	0.14

Pharmagreen Biotech (OTCPK:PHBI) Total Assets Explanation

Total Assets is connected with ROA %.

Pharmagreen Biotech's annualized ROA % for the quarter that ended in Jun. 2023 is

ROA %	=	Net Income (Q: Jun. 2023 )	/	( (Total Assets (Q: Mar. 2023 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	-0.652	/	( (0.163	+	0.14)	/ 2 )
	=	-0.652	/	0.1515
	=	-430.36 %

Note: The Net Income data used here is four times the quarterly (Jun. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Pharmagreen Biotech's Asset Turnover for the quarter that ended in Jun. 2023 is

	Asset Turnover
=	Revenue (Q: Jun. 2023 )	/	( (Total Assets (Q: Mar. 2023 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
=	0.001	/	( (0.163	+	0.14)	/ 2 )
=	0.001	/	0.1515
=	0.01

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Pharmagreen Biotech Total Assets Related Terms

Thank you for viewing the detailed overview of Pharmagreen Biotech's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmagreen Biotech (Pharmagreen Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmagreen Biotech Inc (OTCPK:PHBI) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

112 North Curry Street, Carson, NV, USA, 89703

Website

https://www.pharmagreen.ca

Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.